Balance between cytokine production by peripheral blood mononuclear cells and reactive oxygen species production by monocytes in patients with chronic kidney disease

Renal Failure

Volumn 26, Issue 6, 2004, Pages 673-681

  Sardenberg, Camila ^a   Suassuna, Paulo ^a   Watanabe, Renato ^a   Cruz Andreoli, Maria Cláudia ^a   Dalboni, Maria Aparecida ^a   Seabra, Victor Faria ^a   Draibe, Sérgio Antonio ^a   Neto, Miguel Cendoroglo ^a   Jaber, Bertrand ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Cytokine; Inflammation; Monocyte; Reactive oxygen species

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMODIALYSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEAL DIALYSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; UREMIA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; LEUKOCYTES, MONONUCLEAR; LINEAR MODELS; MALE; MIDDLE AGED; MONOCYTES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PROBABILITY; PROGNOSIS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; RENAL DIALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 9644254142     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200037122     Document Type: Article

References (24)

1. Lewis, S.L.; Van Epps, D.E.; Chenoweth, D.E. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients. Blood Purif. 1987, 5, 138.
2. Descamps-Latscha, B.; Jungers, P. New molecular aspects of chronic uremia and dialysis-related immunocompetent cell activation. Nephrol. Dial. Transplant. 1996, 11, 121.
3. Cohen, G.; Haag-Weber, M.; Horl, W.H. Immune dysfunction in uremia. Kidney Int. 1997, 62 (Suppl.), S79.
4. Wanner, C.; Zimmermann, J.; Quaschning, T.; Galle, J. Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int. 1997, 62 (Suppl.), S53.
5. Bergstrom, J.; Lindholm, B. Malnutrition, cardiac disease, and mortality: an integrated point of view. Am. J. Kidney Dis. 1998, 32, 834.
6. Sarnak, M.J.; Jaber, B.L. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000, 58, 1758.
7. Hoen, B.; Paul-Dauphin, A.; Hestin, D.; Kessler, M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J. Am. Soc. Nephrol. 1998, 9, 869.
8. Witko-Sarsat, V.; Rieu, P.; Descamps-Latscha, B.; Lesavre, P.; Halbwachs-Mecarelli, L. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 2000, 80, 617.
9. Lewis, S.L.; Van Epps, D.E.; Chenoweth, D.E. Alterations in chemotactic factor-induced responses of neutrophils and monocytes from chronic dialysis patients. Clin. Nephrol. 1988, 30, 63.
10. Vanholder, R.; Dell'Aquila, R.; Jacobs, V.; Dhondt, A.; Veys, N.; Waterloss, M.A.; Van Landschoot, N.; Van Biesen, W.; Ringoir, S. Depressed phagocytosis in hemodialyzed patients: in vivo and in vitro mechanisms. Nephron 1993, 63, 409.
11. Metcalf, J.A.; Gallin, J.I.; Nauseef, W.M.; Root, R.K. Laboratory Manual of Neutrophil Function; Raven Press: New York, NY, 1986.
12. Eknoyan, G.; Levin, N. NKF-K/DOQI clinical practice guidelines: up-date 2000. Am. J. Kidney Dis. 2001, 37 (Suppl. 1), 1.
13. Kluth, D.C.; Rees, A.J. Inhibiting inflammatory cytokines. Semin. Nephrol. 1996, 16, 576.
14. Morita, Y.; Yamamura, M.; Kashihara, N.; Makino, H. Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients. Res. Commun. Mol. Pathol. Pharmacol. 1997, 98, 19.
15. Girndt, M.; Sester, M.; Sester, U.; Kaul, H.; Kohler, H. Molecular aspects of T- and B-cell function in uremia. Kidney Int. 2001, 59 (Suppl. 78), S206.
16. Descamps-Latscha, B. The immune system in end-stage renal disease. Curr. Opin. Nephrol. Hypertens. 1993, 2, 883.
17. Descamps-Latscha, B.; Herbelin, A.; Nguyen, A.T.; Roux-Lombard, P.; Zingraff, J.; Moynot, A.; Verger, C.; Dahmane, D.; de Groote, D.; Jungers, P.; et al. Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells. B cells, and monocytes. J. Immunol. 1995, 154, 882.
18. Elbim, C.; Reglier, H.; Fay, M.; Delarche, C.; Andrieu, V.; El Benna, J.; Gougerot-Pocidalo, M.A. Intracellular pool of IL-10 receptors in specific granules of human neutrophils: differential mobilization by proinflammatory mediators. J. Immunol. 2001, 166, 5201.
19. Girndt, M.; Kohler, H.; Schiedhelm-Weick, E.; Schlaak, J.F.; Meyer zum Buschenfelde, K.H.; Fleischer, B. Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int. 1995, 47, 559.
20. Girndt, M.; Heisel, O.; Kohler, H. Influence of dialysis with polyamide vs. hemophan hemodialyzers on monokine and complement activation during a 4-month long-term study. Nephrol. Dial. Transplant. 1999, 14, 676.
21. Girndt, M.; Kaul, H.; Leitnaker, C.K.; Sester, M.; Sester, U.; Kohler, H. Selective sequestration of cytokine-producing monocytes during hemodialysis treatment. Am. J. Kidney Dis. 2001, 37, 954.
22. Van Riemsdijk-van Overbeeke, I.C.; Baan, C.C.; Hesse, C.J.; Loonen, E.H.; Niesters, H.G.; Zietse, R.; Weimar, W. TNF-alpha: mRNA, plasma proteins levels and soluble receptors in patients on hemodialysis, on CAPD and with end-stage renal failure. Clin. Nephrol. 2000, 55, 2.
23. Fine, A. Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney Int. 2002, 61, 2.
24. U.S. Renal Data System. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2003.